News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Svennilson Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
| 01/23/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 37,639 shares
@ $4.9976, valued at
$188.1k
Bought 500 shares
@ $4.996, valued at
$2.5k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 100,070 shares
@ $4.8418, valued at
$484.5k
Bought 209,000 shares
@ $4.76, valued at
$994.8k
|
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2022 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 104,090 shares
@ $4.9871, valued at
$519.1k
Bought 35,058 shares
@ $4.7156, valued at
$165.3k
|
|
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 1,837 shares
@ $12.4549, valued at
$22.9k
Bought 63 shares
@ $12.4549, valued at
$784.7 |
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 9,898 shares
@ $12.4993, valued at
$123.7k
Bought 338 shares
@ $12.4993, valued at
$4.2k
Bought 15,776 shares
@ $12.0021, valued at
$189.3k
Bought 538 shares
@ $12.0021, valued at
$6.5k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 1,208,750 shares
@ $10.6715, valued at
$12.9M
Bought 41,250 shares
@ $10.6715, valued at
$440.2k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 241,750 shares
@ $0
Bought 8,250 shares
@ $0
Bought 579,910 shares
@ $0
Bought 19,791 shares
@ $0 |
|
| 11/16/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,200,000 shares
@ $0
Acquired 287,702 shares
@ $0
Disposed of 287,702 shares
@ $0
Acquired 86,716 shares
@ $0
Acquired 86,716 shares
@ $0
Acquired 74 shares
@ $0
Exercised 16,625 options to buy
@ $16, valued at
$266k
|
|
| 09/29/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 7,500 shares
@ $34.4808, valued at
$258.6k
Sold 1,114 shares
@ $34.965, valued at
$39k
Sold 625 shares
@ $34.9446, valued at
$21.8k
Exercised 7,500 options to buy
@ $28.27, valued at
$212k
Exercised 1,114 options to buy
@ $22.2, valued at
$24.7k
Exercised 625 options to buy
@ $19.3, valued at
$12.1k
|
|
| 09/16/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 1,400 shares
@ $35.7071, valued at
$50k
Sold 29,634 shares
@ $36.7869, valued at
$1.1M
Sold 25,351 shares
@ $37.2705, valued at
$944.8k
Sold 1,700 shares
@ $35.7732, valued at
$60.8k
Sold 42,151 shares
@ $36.916, valued at
$1.6M
Sold 10,807 shares
@ $37.3148, valued at
$403.3k
Sold 1,496 shares
@ $35.7466, valued at
$53.5k
Sold 32,211 shares
@ $36.8528, valued at
$1.2M
Sold 2,926 shares
@ $37.3062, valued at
$109.2k
Sold 11,476 shares
@ $37.2138, valued at
$427.1k
Sold 4,400 shares
@ $37.6732, valued at
$165.8k
|
|
| 09/14/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Disposed of 1,166,666 shares
@ $0
Acquired 279,710 shares
@ $0
Disposed of 279,710 shares
@ $0
Acquired 72 shares
@ $0
Acquired 84,307 shares
@ $0
Acquired 84,307 shares
@ $0
Acquired 48,652 shares
@ $0
Sold 7,187 shares
@ $35.1941, valued at
$252.9k
Sold 7,320 shares
@ $35.1875, valued at
$257.6k
Sold 7,231 shares
@ $35.1949, valued at
$254.5k
Sold 4,803 shares
@ $35.2506, valued at
$169.3k
|
|
| 09/07/2021 |
3
| Column Group II GP, LP (10% Owner) has filed a Form 3 on eFFECTOR Therapeutics, Inc. |
| 09/03/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 6,904 shares
@ $35.0163, valued at
$241.8k
Sold 8,976 shares
@ $35.3915, valued at
$317.7k
Sold 8,805 shares
@ $35.0575, valued at
$308.7k
Sold 7,064 shares
@ $35.4592, valued at
$250.5k
Sold 18,545 shares
@ $35.4318, valued at
$657.1k
Sold 18,556 shares
@ $35.4316, valued at
$657.5k
|
|
| 08/24/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 1,440 shares
@ $30.0879, valued at
$43.3k
Sold 1,429 shares
@ $30.0802, valued at
$43k
Sold 1,670 shares
@ $30.0732, valued at
$50.2k
Sold 7,605 shares
@ $30.9267, valued at
$235.2k
Sold 12,969 shares
@ $31.4113, valued at
$407.4k
Sold 2,200 shares
@ $32.349, valued at
$71.2k
Sold 7,278 shares
@ $30.9187, valued at
$225k
Sold 13,623 shares
@ $31.4035, valued at
$427.8k
Sold 2,007 shares
@ $32.3926, valued at
$65k
Sold 8,204 shares
@ $30.9429, valued at
$253.9k
Sold 12,354 shares
@ $31.4168, valued at
$388.1k
|
|
| 08/20/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Disposed of 1,317,005 shares
@ $0
Acquired 208,403 shares
@ $0
Disposed of 208,403 shares
@ $0
Acquired 91 shares
@ $0
Acquired 64,425 shares
@ $0
Acquired 64,425 shares
@ $0
Acquired 35,746 shares
@ $0 |
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Svennilson Peter (10% Owner) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 16,625 options to buy
@ $19.03, valued at
$316.4k
|
|
|
|
|